CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts

CCND2 has context-dependent roles in cancer, but its prognostic relevance in the major histological subtypes of non-small cell lung cancer remains uncertain. We evaluated CCND2 separately in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) using The Cancer Genome Atlas (TCGA)data from OncoLnc and the Genomic Data Commons, together with three independent Gene Expression Omnibus (GEO) cohorts. Continuous-expression overall survival (OS) models were prespecified as the principal survival analyses. In matched tumor–normal pairs, CCND2 expression was lower in LUAD tumors (p < 0.001), with a nonsignificant difference in LUSC (p = 0.054). In TCGA-LUAD, higher CCND2 expression was associated with a lower mortality hazard after clinical adjustment (HR per SD = 0.839, 95% CI 0.722–0.975, p = 0.022; 0.841 without the pack-years-recorded indicator), with similar estimates in detailed-stage, EGFR-adjusted, and purity-adjusted models. The LUSC association was nonsignificant (HR = 0.888, 95% CI 0.776–1.017, p = 0.085), and a formal histology interaction test was nonsignificant (p = 0.235). Adding CCND2 to clinical models yielded only a small, uncertain gain in the C-index. External associations were heterogeneous and partly probe-dependent, and pooled estimates were nonsignificant in both histologies. Gene correlations were small, and pathway enrichments described bulk-tissue association patterns. CCND2 is an exploratory prognostic candidate in LUAD that requires further validation before clinical application.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-16
DOI
https://doi.org/10.3390/cimb48111230
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts

Yu-Ran Heo, Ji-Hun An, Jae‐Ho Lee, Jin Lee et al.
2 links
Current Issues in Molecular Biology
Lung Cancer Research Studies
article

CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts

Yu-Ran Heo, Ji-Hun An, Jae‐Ho Lee, Jin Lee, Jin-Woo Min, Na-Hyun Park, Uk Jeong
article en

Abstract

CCND2 has context-dependent roles in cancer, but its prognostic relevance in the major histological subtypes of non-small cell lung cancer remains uncertain. We evaluated CCND2 separately in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) using The Cancer Genome Atlas (TCGA)data from OncoLnc and the Genomic Data Commons, together with three independent Gene Expression Omnibus (GEO) cohorts. Continuous-expression overall survival (OS) models were prespecified as the principal survival analyses. In matched tumor–normal pairs, CCND2 expression was lower in LUAD tumors (p < 0.001), with a nonsignificant difference in LUSC (p = 0.054). In TCGA-LUAD, higher CCND2 expression was associated with a lower mortality hazard after clinical adjustment (HR per SD = 0.839, 95% CI 0.722–0.975, p = 0.022; 0.841 without the pack-years-recorded indicator), with similar estimates in detailed-stage, EGFR-adjusted, and purity-adjusted models. The LUSC association was nonsignificant (HR = 0.888, 95% CI 0.776–1.017, p = 0.085), and a formal histology interaction test was nonsignificant (p = 0.235). Adding CCND2 to clinical models yielded only a small, uncertain gain in the C-index. External associations were heterogeneous and partly probe-dependent, and pooled estimates were nonsignificant in both histologies. Gene correlations were small, and pathway enrichments described bulk-tissue association patterns. CCND2 is an exploratory prognostic candidate in LUAD that requires further validation before clinical application.

Current Issues in Molecular BiologyVol. 48(11)
Keimyung University (KR)
Good health and well-being
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon